News | February 16, 2022
Clean Science and Technology to invest Rs. 300 - 500 Cr on expansion
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
Key takeaways of Q3FY22 quarter & conference call highlights
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Key takeaways of recent quarter & conference call highlights
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
Granules India has reported consolidated financial results for the period ended December 31, 2021
Key takeaways of recent quarter & conference call highlights
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
ICICI Direct analysis of Dr Reddy’s Q3FY22 results
Subscribe To Our Newsletter & Stay Updated
